Search Results

Filter
  • 1-5 of  5 results for ""Non-Muscle Invasive Bladder Neoplasms""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Spatial comparison of molecular features associated with resistance to pembrolizumab in BCG unresponsive bladder cancer.

  • Authors : Meghani K; Departments of Urology, and Biochemistry and Molecular Genetics, Feinberg School of Medicine, Chicago, Illinois, USA.; Frydenlund N

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology; Humans

  • Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 16; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 16.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited

Record details

×
Academic Journal

Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial.

  • Authors : Wen F; Abdominal Oncology Ward, Division of Radiation Oncology, Cancer Center, West China Hospital Sichuan University, Chengdu, Sichuan, China.; Lin T

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*; Humans

  • Source: BMJ open [BMJ Open] 2024 Jan 22; Vol. 14 (1), pp. e076663. Date of Electronic Publication: 2024 Jan 22.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited

Record details

×
Academic Journal

Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life.

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology; Male

  • Source: BMJ open [BMJ Open] 2023 Dec 20; Vol. 13 (12), pp. e075942. Date of Electronic Publication: 2023 Dec 20.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited

Record details

×
Academic Journal

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.

  • Authors : Derré L; Urology Research Unit and Urology Biobank, Deptment of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland .; Lucca I

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology

  • Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Dec 14; Vol. 11 (12). Date of Electronic Publication: 2023 Dec 14.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited

Record details

×
Academic Journal

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.

  • Authors : van Puffelen JH; Department of Internal Medicine, Radboudumc, Nijmegen, The Netherlands.; Department for Health Evidence, Radboudumc, Nijmegen, The Netherlands.

Subjects: Non-Muscle Invasive Bladder Neoplasms* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Respiratory Tract Infections*/Respiratory Tract Infections*/Respiratory Tract Infections*/drug therapy

  • Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jan; Vol. 11 (1).Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium:

Record details

×
  • 1-5 of  5 results for ""Non-Muscle Invasive Bladder Neoplasms""